[1] Torabi A, Rigby AS, Cleland JG. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction[J]. J Am Coll Cardiol, 2009, 55(1):79-81.
[2] Hellermann JP, Jacobsen SG, Gersh BJ,et al. Heart failure after myocardial infarction: a review[J]. Am J Med, 2002,113(4):324-330.
[3] Armstrong PW. Left ventricular dysfunction: causes, natural history and hopes for reversal[J]. Heart, 2000, 84(Suppl 1):i15-i17.
[4] Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure[J]. J Am Coll Cardiol, 1992, 20(1):248-254.
[5] Kristensen SL. Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial[J]. Circ Heart Fai, 2016, 9(1):e002560.
[6] Kovacic-Milivojevic' B, Roediger F, Almeida EA, et al. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy[J]. Mol Biol Cell, 2001, 12(8):2290-2307.
[7] Anderson JL, Adam CD, Antman EM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2011, 123(18):e426-e579.
[8] O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2012,127(4):e362-e425.
[9] Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined—a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000, 36(3):959-969.
[10] Scanlon PJ,Faxon DP,Audet AM, et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Coronary Angiography)developed in collaboration with the Society for Cardiac Angiography and Interventions[J]. Circulation, 1999, 99(17):2345-2357.
[11] Wu Z, Sheng H, Chen Y, et al. Copy number variation of the lipoprotein(a)(LPA)gene is associated with coronary artery disease in a southern Han Chinese population[J]. Int J Clin Exp Med, 2014, 7(10):3669-3677.
[12] Rognant N, Lemoine S, Laville M, et al. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients[J]. Diabetes care, 2011, 34(6):1320-1322.
[13] Gottdiener JS, Bednarz J, Devereux R,et al. American society of echocardiography recommendations for use of echocardiography in clinical trials[J]. J Am Soc Echocardiogr, 2004, 17(10):1086-1119.
[14] Raymond I,Pedersen F, Steensgaard-Hansen F,et al. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen[J]. Heart, 2003, 89(12): 1422-1429.
[15] Targher G,Dauriz M,Laroche C. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry[J]. Eur J Heart Fail, 2017, 19(1):54-65.
[16] Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia, 2014, 57(4):660-671.